drugset / Trial / NCT06194032
A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants
RandomizedCrossoverTriple-blindTreatment
Summary
This study will assess the effect of single oral doses of baxdrostat on the ECG interval measured from the onset of the QRS complex to the end of the T wave (QT) interval corrected for HR using Fridericia's formula (QTcF) compared to placebo using a concentration-QTcF analysis, and with moxifloxacin as positive control, in healthy participants.
Timeline
- Start
- 2024-02-29
- Primary completion
- 2024-05-13
- Completion
- 2024-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baxdrostat | Small molecule | — | Oral |
| Subject | Moxifloxacin | Small molecule | — | — |
Indications
No indication recorded.